期刊文献+
共找到8篇文章
< 1 >
每页显示 20 50 100
The emerging roles of transplanted radial glial cells in regenerating the central nervous system
1
作者 Robin E.White Denis S.Barry 《Neural Regeneration Research》 SCIE CAS CSCD 2015年第10期1548-1551,共4页
Scientists conclude that a combination of treatments involving rehabilitation,drug delivery,surgery and cell transplantation are necessary to achieve significant progress in regenerating the injured central nervous sy... Scientists conclude that a combination of treatments involving rehabilitation,drug delivery,surgery and cell transplantation are necessary to achieve significant progress in regenerating the injured central nervous system(CNS). 展开更多
关键词 cell The emerging roles of transplanted radial glial cells in regenerating the central nervous system
下载PDF
Axotomy induces damage to glial cells remote from the transection site in the peripheral nervous system
2
作者 Anatoly B.Uzdensky 《Neural Regeneration Research》 SCIE CAS CSCD 2018年第4期639-640,共2页
Traumatic cerebral or spinal cord injury induced by military,traffic,and sports accidents,falls or environmental and anthropogenic catastrophes are among main causes of people mortality and disability,especially in yo... Traumatic cerebral or spinal cord injury induced by military,traffic,and sports accidents,falls or environmental and anthropogenic catastrophes are among main causes of people mortality and disability,especially in young and middle age men(Kobeissy,2015).Axon transection,or axotomy,occurs in wounds and during surgery. 展开更多
关键词 Axotomy induces damage to glial cells remote from the transection site in the peripheral nervous system CSR
下载PDF
Stem cells:a promising candidate to treat neurological disorders 被引量:7
3
作者 Chang-Geng Song Yi-Zhe Zhang +5 位作者 Hai-Ning Wu Xiu-Li Cao Chen-Jun Guo Yong-Qiang Li Min-Hua Zheng Hua Han 《Neural Regeneration Research》 SCIE CAS CSCD 2018年第7期1294-1304,共11页
Neurologic impairments are usually irreversible as a result of limited regeneration in the central nervous system.Therefore,based on the regenerative capacity of stem cells,transplantation therapies of various stem ce... Neurologic impairments are usually irreversible as a result of limited regeneration in the central nervous system.Therefore,based on the regenerative capacity of stem cells,transplantation therapies of various stem cells have been tested in basic research and preclinical trials,and some have shown great prospects.This manuscript overviews the cellular and molecular characteristics of embryonic stem cells,induced pluripotent stem cells,neural stem cells,retinal stem/progenitor cells,mesenchymal stem/stromal cells,and their derivatives in vivo and in vitro as sources for regenerative therapy.These cells have all been considered as candidates to treat several major neurological disorders and diseases,owing to their self-renewal capacity,multi-directional differentiation,neurotrophic properties,and immune modulation effects.We also review representative basic research and recent clinical trials using stem cells for neurodegenerative diseases,including Parkinson's disease,Alzheimer's disease,and age-related macular degeneration,as well as traumatic brain injury and glioblastoma.In spite of a few unsuccessful cases,risks of tumorigenicity,and ethical concerns,most results of animal experiments and clinical trials demonstrate efficacious therapeutic effects of stem cells in the treatment of nervous system disease.In summary,these emerging findings in regenerative medicine are likely to contribute to breakthroughs in the treatment of neurological disorders.Thus,stem cells are a promising candidate for the treatment of nervous system diseases. 展开更多
关键词 nerve regeneration stem cells transplantation stem cell therapy nervous system neurodegenerative disease neurological disorders animal experiment clinical trial regenerative medicine neural regeneration
下载PDF
Effect of glial cells on remyelination after spinal cord injury 被引量:8
4
作者 Hai-feng Wang Xing-kai Liu +10 位作者 Rui Li Ping Zhang Ze Chu Chun-li Wang Hua-rui Liu Jun Qi Guo-yue Lv Guang-yi Wang Bin Liu Yan Li Yuan-yi Wang 《Neural Regeneration Research》 SCIE CAS CSCD 2017年第10期1724-1732,共9页
Remyelination plays a key role in functional recovery of axons after spinal cord injury.Glial cells are the most abundant cells in the central nervous system.When spinal cord injury occurs,many glial cells at the lesi... Remyelination plays a key role in functional recovery of axons after spinal cord injury.Glial cells are the most abundant cells in the central nervous system.When spinal cord injury occurs,many glial cells at the lesion site are immediately activated,and different cells differentially affect inflammatory reactions after injury.In this review,we aim to discuss the core role of oligodendrocyte precursor cells and crosstalk with the rest of glia and their subcategories in the remyelination process.Activated astrocytes influence proliferation,differentiation,and maturation of oligodendrocyte precursor cells,while activated microglia alter remyelination by regulating the inflammatory reaction after spinal cord injury.Understanding the interaction between oligodendrocyte precursor cells and the rest of glia is necessary when designing a therapeutic plan of remyelination after spinal cord injury. 展开更多
关键词 nerve regeneration spinal cord injury remyelination oligodendrocyte precursor cells astrocytes oligodendrocytes microglia glial scar demyelination myelin central nervous system neural regeneration
下载PDF
远志寡糖酯化合物的神经保护作用及初步构效关系研究 被引量:21
5
作者 黄志雄 穆丽华 +2 位作者 赵海霞 封聚强 刘屏 《解放军药学学报》 CAS 2012年第5期377-380,384,共5页
目的研究远志中寡糖酯类化合物的神经保护作用和探讨化合物的初步构效关系。方法采用MTT法和BrdU标记法评价寡糖酯单体化合物对神经细胞的保护作用。结果在体外皮质酮诱导的SH-SY5Y神经细胞损伤模型上,化合物tenifoliside A、tenuifolio... 目的研究远志中寡糖酯类化合物的神经保护作用和探讨化合物的初步构效关系。方法采用MTT法和BrdU标记法评价寡糖酯单体化合物对神经细胞的保护作用。结果在体外皮质酮诱导的SH-SY5Y神经细胞损伤模型上,化合物tenifoliside A、tenuifoliose J、tenuifolioses A、1-o-(E)-Benzoyl-[3-o-(E)-Alphatolluyl]-β-D-fructofuranosy-(2→1)-[β-D-glu-copyranosyl-(1→2)]-α-D-gluc-opyranosid表现出了很好的神经保护作用,并呈一定的剂量依赖性。结论远志寡糖酯类化合物对皮质酮诱导损伤的SH-SY5Y神经细胞有保护作用,其保护作用强弱与化合物类型及其浓度,化合物的母核结构,取代基位置和取代基种类有关。 展开更多
关键词 远志 寡糖酯 SH—SY5Y细胞 神经保护 构效关系
下载PDF
Advantages of Rho-associated kinases and their inhibitor fasudil for the treatment of neurodegenerative diseases 被引量:4
6
作者 Qing Wang Li-Juan Song +4 位作者 Zhi-Bin Ding Zhi Chai Jie-Zhong Yu Bao-Guo Xiao Cun-Gen Ma 《Neural Regeneration Research》 SCIE CAS CSCD 2022年第12期2623-2631,共9页
Ras homolog(Rho)-associated kinases(ROCKs)belong to the serine-threonine kinase family,which plays a pivotal role in regulating the damage,survival,axon guidance,and regeneration of neurons.ROCKs are also involved in ... Ras homolog(Rho)-associated kinases(ROCKs)belong to the serine-threonine kinase family,which plays a pivotal role in regulating the damage,survival,axon guidance,and regeneration of neurons.ROCKs are also involved in the biological effects of immune cells and glial cells,as well as the development of neurodegenerative disorders such as Alzheimer’s disease,Parkinson’s disease,and multiple sclerosis.Previous studies by us and others confirmed that ROCKs inhibitors attenuated the symptoms and progression of experimental models of the abovementioned neurodegenerative diseases by inhibiting neuroinflammation,regulating immune imbalance,repairing the blood-brain barrier,and promoting nerve repair and myelin regeneration.Fasudil,the first ROCKs inhibitor to be used clinically,has a good therapeutic effect on neurodegenerative diseases.Fasudil increases the activity of neural stem cells and mesenchymal stem cells,thus optimizing cell therapy.This review will systematically describe,for the first time,the effects of abnormal activation of ROCKs on T cells,B cells,microglia,astrocytes,oligodendrocytes,and pericytes in neurodegenerative diseases of the central nervous system,summarize the therapeutic potential of fasudil in several experimental models of neurodegenerative diseases,and clarify the possible cellular and molecular mechanisms of ROCKs inhibition.This review also proposes that fasudil is a novel potential treatment,especially in combination with cell-based therapy.Findings from this review add support for further investigation of ROCKs and its inhibitor fasudil for the treatment of neurodegenerative diseases. 展开更多
关键词 Alzheimer’s disease cell-based therapy central nervous system cells FASUDIL IMMUNOCYTES multiple sclerosis Parkinson’s disease PERICYTES Rho kinase inhibitor Rho-associated kinases
下载PDF
Embracing oligodendrocyte diversity in the context of perinatal injury 被引量:1
7
作者 Jessie Newville Lauren L.Jantzie Lee Anna Cunningham 《Neural Regeneration Research》 SCIE CAS CSCD 2017年第10期1575-1585,共11页
Emerging evidence is fueling a new appreciation of oligodendrocyte diversity that is overturning the traditional view that oligodendrocytes are a homogenous cell population.Oligodendrocytes of distinct origins,maturat... Emerging evidence is fueling a new appreciation of oligodendrocyte diversity that is overturning the traditional view that oligodendrocytes are a homogenous cell population.Oligodendrocytes of distinct origins,maturational stages,and regional locations may differ in their functional capacity or susceptibility to injury.One of the most unique qualities of the oligodendrocyte is its ability to produce myelin.Myelin abnormalities have been ascribed to a remarkable array of perinatal brain injuries,with concomitant oligodendrocyte dysregulation.Within this review,we discuss new insights into the diversity of the oligodendrocyte lineage and highlight their relevance in paradigms of perinatal brain injury.Future therapeutic development will be informed by comprehensive knowledge of oligodendrocyte pathophysiology that considers the particular facets of heterogeneity that this lineage exhibits. 展开更多
关键词 oligodendrogenesis oligodendrocyte progenitor cell myelination central nervous system development ontogenetic origin white matter white matter injury preterm birth glia macroglia
下载PDF
"微移植"治疗难治性原发中枢神经系统淋巴瘤的临床分析 被引量:1
8
作者 刘娟 孙万军 +4 位作者 郗晓芹 黄晓梅 李晓希 夏娇 曲媛媛 《中国实验血液学杂志》 CAS CSCD 北大核心 2018年第2期432-436,共5页
目的:观察以大剂量甲氨蝶呤(MTX)为基础的化疗联合亲缘单倍体相合供者G-CSF动员后外周血造血干细胞(G-PBHSC)输注组成的"微移植",治疗3例难治性原发中枢神经系统淋巴瘤(PCNSL)患者的疗效。方法:2014年3月至2015年9月火箭军总... 目的:观察以大剂量甲氨蝶呤(MTX)为基础的化疗联合亲缘单倍体相合供者G-CSF动员后外周血造血干细胞(G-PBHSC)输注组成的"微移植",治疗3例难治性原发中枢神经系统淋巴瘤(PCNSL)患者的疗效。方法:2014年3月至2015年9月火箭军总医院血液科收治的3例难治性PCNSL患者。"微移植"治疗时首先给予患者大剂量MTX为基础的化疗,在化疗结束后48 h给予亲缘单倍体相合供者G-PBHSC输注,输注的单个核细胞(MNC)中位数1.34×108/kg,不进行移植物抗宿主病(GVHD)预防。结果:3例患者在确诊后分别接受过化疗或放疗,在"微移植"治疗前病情处于进展状态,"微移植"治疗后1例患者获得完全缓解,并已持续15个月。2例患者获得部分缓解,病情稳定10个月和7个月,此后病情再次进展而死亡。患者对"微移植"治疗的耐受性好,不良反应主要是与大剂量MTX化疗相关的中性粒细胞减少、血小板减少和感染,但在G-PBHSC输注后患者中性粒细胞和血小板恢复的中位时间分别为11 d、12.5 d。在治疗期间未观察到GVHD相关临床表现。结论:对于难治性PCNSL患者,"微移植"是一个值得尝试的挽救性治疗方法。 展开更多
关键词 原发中枢神经系统淋巴瘤 难治性原发中枢神经系统淋巴瘤 甲氨蝶呤化疗 外周血造血干细胞输注G-CSF
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部